Curiosity Science

Researchers have developed a multifunctional p–n diode that can sense light, store data, and process information—all in one device. Built using GaN/AlGaN nanowire structures, this diode creates an “electron reservoir” that enables controlled charge trapping, allowing it to act like both a sensor and a memory unit.

Unlike traditional systems that require separate components, this three-in-one architecture can directly process images—performing tasks like denoising and classification without extra circuits.

The result? Smaller, faster, and more energy-efficient image sensors—pushing us closer to neuromorphic hardware (electronics that mimic brain-like processing).

This innovation could transform everything from smartphones to AI edge devices.

Reference:
Luo Y. et al. (2026). A single diode with integrated photosensing, memory and processing for neuromorphic image sensors. Nature Electronics.

China has approved the world’s first commercially available brain-computer interface (BCI) medical device, marking a major step toward real clinical use of neurotechnology.

The device, developed by Borui Kang Medical Technology (Shanghai), is designed for people with quadriplegia caused by cervical spinal cord injuries. It works by implanting electrodes near the brain that can read neural signals and translate them into movement commands. Through a connected robotic glove, patients can regain hand-grasping ability, allowing them to perform basic actions like holding objects again.

Unlike many experimental systems, this BCI uses minimally invasive extradural implantation and wireless communication. Clinical trials showed significant improvements in hand movement and quality of life for participants.

Experts believe that as BCI technology advances, we may soon see broader applications—restoring movement, enabling communication for paralyzed patients, and even creating new ways for the brain to interact with machines.

Reference:
Reuters (2026) – “China approves market launch of brain-computer interface medical device in world first.”
Wolpaw & Wolpaw (2012). Brain-Computer Interfaces: Principles and Practice. Oxford University Press.

Scientists are reconstructing the oldest known star map, believed to be created by Hipparchus around 190–120 BCE. The map was hidden beneath later writings in a reused manuscript called Codex Climaci Rescriptus.

Researchers are scanning the parchment using a synchrotron X-ray accelerator at SLAC National Accelerator Laboratory. The scans detect chemical differences in ink, revealing Greek astronomical text beneath Syriac writing. Early results already show star coordinates and a reference to the constellation Aquarius.

This discovery could help scientists understand how ancient astronomers mapped the sky with remarkable accuracy using only naked-eye observations.

Source: ScienceAlert (David Nield, 8 March 2026); KQED interview with Victor Gysembergh.

In lab studies, purified plum polyphenols (PPP) — especially quercitrin — reduced growth of A549 lung cancer cells by triggering apoptosis (programmed cell death).

They work by blocking the PI3K/AKT/FOXO1 pathway, a key survival route cancer cells use. By inhibiting AKT phosphorylation, the extract shuts down growth signals and activates cell death.

At higher doses, PPP showed stronger inhibition than vitamin C in vitro.

⚠️ Lab study only — not a clinical treatment yet.

Source: Li et al., Plant Foods for Human Nutrition.

Sometimes science advances extremely slowly. A famous example is the Pitch Drop Experiment, the world’s longest-running laboratory experiment, which has been ongoing for nearly a century.

The experiment began in 1927 at the University of Queensland, when physicist Thomas Parnell filled a sealed glass funnel with pitch (a tar-derived substance used for waterproofing ships). Pitch appears solid at room temperature but is actually a fluid (a substance that can flow) with extremely high viscosity (resistance to flow)—about 100 billion times thicker than water.

In 1930, Parnell cut the funnel’s stem, officially starting the experiment. The pitch began flowing so slowly that it took eight years for the first drop to fall into the beaker below. Since then, drops have fallen roughly once every eight years, slowing further after air conditioning (temperature control system) was installed in the 1980s.

As of 2026, only nine drops have fallen. The most recent drop occurred in 2014.

Remarkably, no one has ever directly seen a drop fall. Even with cameras and a live stream, each drop has occurred during technical failures or interruptions.

After Parnell’s death, physicist John Mainstone became custodian in 1961. He supervised the experiment for 52 years but never witnessed a drop fall. He missed one in 2000 due to a thunderstorm disrupting the live feed and passed away shortly before the 2014 drop.

Today, physics professor Andrew White is the current custodian, patiently waiting for the 10th drop, expected sometime in the 2020s.

Nearly 100 years on, the Pitch Drop Experiment continues—quietly demonstrating that some scientific truths reveal themselves only with extraordinary patience.

Researchers at Texas A&M University have developed an advanced vessel-on-a-chip (a micro-engineered device that mimics human blood vessels) that recreates the real structure of human blood vessels, rather than using simple straight channels.

What’s new

The chip can replicate:

Branching vessels (points where a vessel splits)
Stenosis (abnormal narrowing of a blood vessel)
Aneurysm-like expansion (localized widening of a blood vessel)

These features strongly affect blood flow and are common sites where vascular disease begins.

Why it matters

Realistic vessel shapes change shear stress (frictional force of blood flow on vessel walls), which directly influences endothelial cells (cells lining the inside of blood vessels). Abnormal shear stress can trigger vessel damage and disease progression.

This platform allows scientists to:

Study vascular disease under physiological conditions (conditions similar to the human body)
Test drugs more accurately
Reduce reliance on animal models

Research details

The device was designed by Jennifer D. Lee in the lab of Abhishek Jain and builds on earlier straight-vessel models. The study was published in Lab on a Chip.

Future plans

Researchers aim to add more vascular cell types to study cell–cell interactions (how different cells affect each other) under realistic blood flow.

Source
“Scientists Replicate Real Blood Vessels To Unlock New Treatments for Vascular Disease”
Published January 29, 2026
Original research: Lee JD et al., Lab on a Chip, March 5, 2025
DOI: 10.1039/D4LC00968A

Early Dementia Signals Hidden in Terry Pratchett’s Writing

Scientists have identified subtle early signs of dementia by analyzing changes in the language of Terry Pratchett, one of Britain’s most celebrated writers.

Key Finding

Researchers examined Pratchett’s Discworld novels and found a gradual decline in lexical diversity, especially in the use of adjectives.

Vocabulary became slightly narrower

Descriptive richness reduced over time

Changes were statistically significant but imperceptible to casual readers

The earliest clear drop appeared in The Last Continent, published nearly 10 years before Pratchett’s formal diagnosis.

Why This Matters

Dementia, including Alzheimer’s disease, does not begin with obvious memory loss. Early stages often affect:

Attention

Perception

Language

Language is tightly linked to brain function, making it a valuable early indicator of neurological change.

Broader Implications

Dementia has a long preclinical phase, when brain changes occur without clear symptoms

Linguistic analysis could support early detection alongside:

Cognitive testing

Brain imaging

Biological markers

Because people already produce large amounts of written text (emails, messages, documents), this approach could be:

Noninvasive

Cost-effective

Useful with proper privacy safeguards

Impact on Treatment

Early detection is critical as new Alzheimer’s drugs work best before major brain damage.
Examples include:

Lecanemab

Donanemab

These treatments aim to slow disease progression, not just manage symptoms.

Takeaway

Terry Pratchett’s legacy now extends beyond literature. His novels show that dementia can quietly influence language years before diagnosis, offering a powerful insight into how earlier, gentler signals might transform future detection and care.

Two days of oatmeal significantly lowers cholesterol, study shows

A randomized clinical trial from University of Bonn reports that just two days of an intensive oat-based diet can meaningfully reduce harmful cholesterol levels in people with metabolic syndrome.

Participants consumed 300 grams of oatmeal per day for two days while following a calorie-restricted diet. Compared with a control group on a non-oat calorie-reduced diet, those eating oats showed a ~10% reduction in LDL (“bad”) cholesterol, along with modest weight loss and lower blood pressure. Notably, the cholesterol-lowering effect persisted for up to six weeks.

The researchers traced this benefit to changes in the gut microbiome. Oats promoted the growth of beneficial intestinal bacteria that produce phenolic compounds, including ferulic acid, which is known to support healthier cholesterol metabolism. At the same time, the diet reduced microbial pathways linked to insulin resistance—an important factor in diabetes risk.

A longer, six-week intervention with smaller daily amounts of oats (80 g/day) produced only minor effects, suggesting that short, intensive oat-based interventions may be more effective than prolonged low-dose intake.

The findings highlight a simple, low-cost dietary strategy that could help reduce cardiovascular and metabolic risk when used periodically.

Key takeaway: A short, high-dose oatmeal intervention can rapidly and sustainably lower LDL cholesterol by reshaping the gut microbiome.

📄 Reference:
Klümpen, L. et al., Cholesterol-lowering effects of oats induced by microbially produced phenolic metabolites in metabolic syndrome: a randomized controlled trial, Nature Communications (2026). DOI: 10.1038/s41467-026-68303-9

For decades, the human heart was thought to be largely incapable of repairing itself after injury. A new study now challenges that belief, showing that human heart muscle cells can regenerate after a heart attack, although at a limited level.

When blood flow is blocked during a heart attack, oxygen-starved heart muscle cells die. The heart typically repairs the damage with scar tissue, which cannot contract. This weakens the heart and raises the risk of future heart failure. While animals like mice can regenerate heart muscle, humans were believed to lack this ability.

Researchers led by Robert Hume at the University of Sydney examined living human heart tissue from organ donors and patients undergoing bypass surgery. Using RNA sequencing, protein analysis, and metabolic profiling, they directly observed human cardiomyocytes re-entering the cell cycle and dividing after injury.

The study also identified specific genes, proteins, and metabolites linked to this regeneration, many of which were previously seen only in animal models. While the natural response is not strong enough to fully repair the heart, it proves that the human heart has an intrinsic regenerative capacity.

The findings open the door to future therapies that could boost this natural repair process, potentially transforming treatment for heart attack survivors and reducing long-term heart failure risk.

📄 Reference: Hume R. et al., Circulation Research (2026).

Hashtags:

A large new study confirms that gut bacteria, not fungi, are the main drivers of auto-brewery syndrome (ABS), a rare condition where the body produces alcohol internally after meals. Researchers found that certain microbes ferment carbohydrates into ethanol inside the gut, raising blood alcohol levels enough to cause real intoxication.

The study, led by scientists at Massachusetts General Hospital and University of California San Diego, analyzed stool samples from ABS patients and their household partners. This allowed researchers to rule out diet and environment as explanations.

Two bacteria stood out:

Klebsiella pneumoniae

Escherichia coli

These microbes were far more abundant in ABS patients, especially during symptom “flare-ups,” and produced large amounts of ethanol when grown in the lab. Blood alcohol levels rose in parallel.

For many patients, the consequences are serious — liver damage, job loss, legal trouble, and social stigma. Some are even accused of secretly drinking.

In a striking case, one patient entered long-term remission after two f***l microbiota transplants, effectively resetting his gut ecosystem. His family reported his normal behavior had “essentially returned.”

The findings suggest future treatments may focus on:

Restoring healthy gut bacteria

Probiotics or diet-based interventions

Targeting bacterial ethanol-production pathways

The study also raises a bigger question: How common is low-level alcohol production in the general population, and could it contribute to liver disease even without drinking?

Reference:
Hsu et al., Nature Microbiology (2025).

Researchers at the Indian Institute of Science (IISC), working with collaborators from the Institute of Mathematical Sciences, have uncovered a key defense strategy used by Mycobacterium tuberculosis (Mtb): a protein called Lsr2 that detects and shuts down foreign DNA embedded in the bacterial genome.

Why this matters
Foreign DNA—often introduced by viruses—can disrupt essential bacterial processes. To stay viable and infectious, Mtb must identify and silence these risky genetic inserts.

What the team found

Selective binding: Lsr2 preferentially binds AT-rich DNA regions, which are typical of foreign genes, in an otherwise GC-rich Mtb genome.

Co-condensation: When many Lsr2 molecules accumulate, they stick together, forming protein–DNA condensates that compact the genome locally.

Gene silencing: This condensation physically blocks the transcription machinery, preventing harmful genes from being expressed.

How they proved it
Using single-molecule DNA imaging, advanced microscopy, and computer simulations, the team visualized how Lsr2 attaches to DNA and identified the protein regions responsible for DNA binding and protein–protein linking—both essential for condensate formation.

Implications for TB treatment
Because Lsr2 is crucial for Mtb infection, disrupting its condensation mechanism could leave the bacterium vulnerable. Targeting Lsr2’s binding or self-assembly domains offers a promising drug strategy against tuberculosis.

Reference
Gaur P. et al. Sequence-dependent co-condensation of Lsr2 with DNA elucidates the mechanism of genome compaction in Mycobacterium tuberculosis. Nucleic Acids Research (2026). DOI: 10.1093/nar/gkaf1428